Conmed (CNMD) Gains from Investment Securities (2022 - 2026)
Conmed (CNMD) posted Gains from Investment Securities of $722000.0 for Q1 2026, down 96.29% on a QoQ basis from $19.4 million in Q4 2025, and down 81.78% year-over-year from $4.0 million in Q1 2025.
Conmed (CNMD) Gains from Investment Securities (2022 - 2026) Analysis & Trends
Conmed's Gains from Investment Securities history runs 5 years deep, the most recent figure standing at $722000.0 for Q1 2026.
- Quarterly Gains from Investment Securities fell 81.78% year-over-year to $722000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.7 million (up 164.54% YoY) and the FY2025 annual result came in at $23.0 million, up 155.91% from the prior year.
- Gains from Investment Securities was $722000.0 for Q1 2026 at Conmed, down from $19.4 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $19.4 million in Q4 2025 and bottomed at -$27.0 million in Q3 2024.
- A 5-year average of -$1.2 million and a median of $970500.0 in 2024 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2024 — Gains from Investment Securities sank 1261.54% — and 2025, when it jumped 1495.32%.
- Conmed's Gains from Investment Securities stood at $2.5 million in 2022, then tumbled by 472.12% to -$9.4 million in 2023, then soared by 113.01% to $1.2 million in 2024, then soared by 1495.32% to $19.4 million in 2025, then sank by 96.29% to $722000.0 in 2026.
- Business Quant data shows CNMD's Gains from Investment Securities at $722000.0 in Q1 2026, $19.4 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Conmed | 1.33 Bn | 1.29 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 722,000.00 |
| Mar 31, 2026 | 722,000.00 |
| Dec 31, 2025 | 19.45 Mn |
| Dec 31, 2025 | 19.45 Mn |
| Sep 30, 2025 | 1.34 Mn |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | -1.80 Mn |
| Jun 30, 2025 | -1.80 Mn |
| Mar 31, 2025 | 3.96 Mn |
| Mar 31, 2025 | 3.96 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | -27.05 Mn |
| Sep 30, 2024 | -27.05 Mn |
| Jun 30, 2024 | -8.67 Mn |
| Jun 30, 2024 | -8.67 Mn |
| Mar 31, 2024 | -6.55 Mn |
| Mar 31, 2024 | -6.55 Mn |
| Dec 31, 2023 | -9.37 Mn |
| Dec 31, 2023 | -9.37 Mn |